RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Investor Relations

Home  >  Investor Relations  >  Overview

Why Invest

Leading positions
in attractive markets

Serving >500,000 customers to advance science and improve health

Solid strategy
with focus and balance

Expanding market leadership with
5 Pillars of Growth

Strong balance sheet

Supporting disciplined capital allocation

Healthy cash flow

Solid track record of strong operating cash flow

Premium brand

Trusted by students to Nobel Prize Laureates

Commitment to ESG

Determined to leave no country behind

Capital Markets Day 2024

Join QIAGEN's Capital Markets Day, Monday, June 17, at the New York Stock Exchange for strategic updates and mid-term ambitions.

2024 AGM

A webcast of the Annual General Meeting of Shareholders of QIAGEN N.V. ("AGM") will be hosted on Friday, June 21, 2024, at 10:00 a.m. (CET)

Events & Presentations

View all Events & Presentations